D&D Pharmatech (347850.KQ)

KRW 47200.0

(0.21%)

Revenue Summary of D&D Pharmatech

D&D Pharmatech's latest annual revenue in 2023 was 18.67 Billion KRW , up 2958.97% from previous year.
D&D Pharmatech's latest quarterly revenue in 2024 Q2 was 2.31 Billion KRW , up 4.31% from previous quarter.
D&D Pharmatech reported a annual revenue of 610.56 Million KRW in annual revenue 2022, down -55.24% from previous year.
D&D Pharmatech reported a annual revenue of 1.36 Billion KRW in annual revenue 2021, down 0.0% from previous year.
D&D Pharmatech reported a quarterly revenue of 2.22 Billion KRW for 2024 Q1, up 23.01% from previous quarter.
D&D Pharmatech reported a quarterly revenue of 1.8 Billion KRW for 2023 Q4, down -74.19% from previous quarter.

Annual Revenue Chart of D&D Pharmatech (2023 - 2019)

Historical Annual Revenue of D&D Pharmatech (2023 - 2019)

Year	Revenue	Revenue Growth
2023	18.67 Billion KRW	2958.97%
2022	610.56 Million KRW	-55.24%
2021	1.36 Billion KRW	0.0%
2020	- KRW	0.0%
2019	- KRW	0.0%

Year	Revenue	Revenue Growth
2024 Q2	2.31 Billion KRW	4.31%
2024 Q1	2.22 Billion KRW	23.01%
2023 Q4	1.8 Billion KRW	-74.19%
2023 FY	18.67 Billion KRW	2958.97%
2023 Q3	6.99 Billion KRW	-27.91%
2023 Q2	9.7 Billion KRW	96.5%
2023 Q1	4.93 Billion KRW	3684.64%
2022 FY	610.56 Million KRW	-55.24%
2022 Q4	130.48 Million KRW	0.0%
2021 FY	1.36 Billion KRW	0.0%
2020 FY	- KRW	0.0%
2019 FY	- KRW	0.0%

Peer Revenue Comparison of D&D Pharmatech

Name	Revenue	Revenue Difference
HLB Co., Ltd.	42.9 Billion KRW	56.464%
iNtRON Biotechnology, Inc.	9.58 Billion KRW	-94.848%
BINEX Co., Ltd.	154.82 Billion KRW	87.937%
Bioneer Corporation	263.23 Billion KRW	92.905%
Anterogen.Co.,Ltd.	6.5 Billion KRW	-187.328%
MEDIPOST Co., Ltd.	68.64 Billion KRW	72.791%
CrystalGenomics, Inc.	4.87 Billion KRW	-282.831%
Helixmith Co., Ltd	4.2 Billion KRW	-344.52%
Chabiotech Co.,Ltd.	953.95 Billion KRW	98.042%
Medy-Tox Inc.	221.12 Billion KRW	91.553%
Peptron, Inc.	3.34 Billion KRW	-458.876%
Amicogen, Inc.	159.9 Billion KRW	88.32%
Genexine, Inc.	4.42 Billion KRW	-321.925%
HLB Therapeutics Co.,Ltd.	53.74 Billion KRW	65.251%
LegoChem Biosciences, Inc.	34.14 Billion KRW	45.302%
ALTEOGEN Inc.	96.52 Billion KRW	80.65%
PharmaResearch Co., Ltd.	261.01 Billion KRW	92.844%
SillaJen, Inc.	3.93 Billion KRW	-374.09%
JETEMA, Co., Ltd.	58.71 Billion KRW	68.191%
OliX Pharmaceuticals,Inc	17.06 Billion KRW	-9.451%
Genomictree Inc.	3.41 Billion KRW	-446.431%
MedPacto, Inc.	- KRW	-Infinity%
EASY BIO,Inc.	165.38 Billion KRW	88.707%
GI Innovation, Inc.	5.31 Billion KRW	-251.148%